- Home
- DCTH vs PSNYW Comparison
DCTH vs PSNYW Comparison
Compare DCTH & PSNYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- PSNYW
- Stock Information
- Founded
- DCTH 1988
- PSNYW 2017
- Country
- DCTH United States
- PSNYW Sweden
- Employees
- DCTH N/A
- PSNYW 2547
- Industry
- DCTH Medical/Dental Instruments
- PSNYW Auto Manufacturing
- Sector
- DCTH Health Care
- PSNYW Consumer Discretionary
- Exchange
- DCTH Nasdaq
- PSNYW Nasdaq
- Market Cap
- DCTH 394.9M
- PSNYW 348.4M
- IPO Year
- DCTH N/A
- PSNYW N/A
- Fundamental
- Price
- DCTH $10.89
- PSNYW $0.16
- Analyst Decision
- DCTH Strong Buy
- PSNYW
- Analyst Count
- DCTH 4
- PSNYW 0
- Target Price
- DCTH $24.50
- PSNYW N/A
- AVG Volume (30 Days)
- DCTH 825.0K
- PSNYW 43.4K
- Earning Date
- DCTH 08-06-2025
- PSNYW 03-06-2025
- Dividend Yield
- DCTH N/A
- PSNYW N/A
- EPS Growth
- DCTH N/A
- PSNYW N/A
- EPS
- DCTH 0.06
- PSNYW N/A
- Revenue
- DCTH $70,240,000.00
- PSNYW $2,034,261,000.00
- Revenue This Year
- DCTH $160.46
- PSNYW N/A
- Revenue Next Year
- DCTH $42.87
- PSNYW $79.49
- P/E Ratio
- DCTH $195.18
- PSNYW N/A
- Revenue Growth
- DCTH 491.35
- PSNYW N/A
- 52 Week Low
- DCTH $8.08
- PSNYW $0.09
- 52 Week High
- DCTH $18.23
- PSNYW $0.61
- Technical
- Relative Strength Index (RSI)
- DCTH 48.16
- PSNYW 51.25
- Support Level
- DCTH $10.06
- PSNYW $0.15
- Resistance Level
- DCTH $10.81
- PSNYW $0.17
- Average True Range (ATR)
- DCTH 0.71
- PSNYW 0.02
- MACD
- DCTH 0.13
- PSNYW 0.00
- Stochastic Oscillator
- DCTH 28.57
- PSNYW 43.06
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.